In the first year after the Accreditation Council for Graduate Medical Education (ACGME) reduced the number of continuous hours that residents can work, there was no change in the rate of death or readmission among hospitalized Medicare patients, according to a new study. The study was led by researchers at the Perelman School of Medicine at the University of Pennsylvania and The Children
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:40:00No increase in patient deaths or hospital readmissions following restrictions to medical residents’ hours
Imagine this scenario: You’ve been feeling persistently blue lately, so you pull out your phone. Instead of asking Siri to tell you a joke, though, you open an app that records you simply talking about your day. A few hours later, your therapist sends you a message asking if you’d like to meet.
A program like this one that analyses your speech and uses it to gain information about your mental health could soon be feasible, thanks in part to research from the University of Maryland showing that certain vocal features change as patients’ feelings of depression worsen.
The research is part of an interdisciplinary initiative at the University of Maryland to engineer patient-focused mental health monitoring systems. Rather than relying solely on patients’ self-reports, these systems could monitor both physical and psychological symptoms of mental illness on a regular basis and provide both patients and their mental health providers with feedback about their status.
To conduct a quantitative experiment on the vocal characteristics of depression acoustician Carol Espy-Wilson and her colleagues repurposed a dataset collected from a 2007 study from an unaffiliated lab also investigating the relationship between depression and speech patterns. The earlier study assessed patients’ depression levels each week using the Hamilton Depression Scale (a standard clinical evaluation tool to measure the severity of depression) and then recorded them speaking freely about their day.
The University of Maryland researchers used data from six patients who, over the six-week course of the previous study, had registered as depressed some weeks and not depressed other weeks. They compared these patients’ Hamilton scores with their speech patterns each week, and found a correlation between depression and certain acoustic properties.
When patients’ feelings of depression were worst, their speech tended to be breathier and slower. The team also found increases in jitter and shimmer, two measures of acoustic disturbance that measure the frequency and amplitude variation of the sound, respectively. Speech high in jitter and shimmer tends to sound hoarse or rough.
The researchers plan to repeat the study in a larger population, this time comparing speech patterns in individuals with no history of mental illness to those with depression to create an acoustic profile of depression-typical speech. A phone app could use this information to analyse patients’ speech, identify acoustic signatures of depression and provide feedback and support.
Espy-Wilson hopes the interactive technology will appeal to teens and young adults, a particularly vulnerable group for mental health problems. ‘Their emotions are all over the place during this time, and that’s when they’re really at risk for depression. We have to reach out and figure out a way to help kids in that stage,’ she said.
EurekAlert
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:40:08The digital therapist
Pushing new frontiers in dementia research, Nanyang Technological University, Singapore (NTU Singapore) scientists have found a new way to treat dementia by sending electrical impulses to specific areas of the brain to enhance the growth of new brain cells.
Known as deep brain stimulation, it is a therapeutic procedure that is already used in some parts of the world to treat various neurological conditions such as tremors or Dystonia, which is characterised by involuntary muscle contractions and spasms.
NTU scientists have discovered that deep brain stimulation could also be used to enhance the growth of brain cells which mitigates the harmful effects of dementia-related conditions and improves short and long-term memory.
Their research has shown that new brain cells, or neurons, can be formed by stimulating the front part of the brain which is involved in memory retention using minute amounts of electricity.
The increase in brain cells reduces anxiety and depression, and promotes improved learning, and boosts overall memory formation and retention.
The research findings open new opportunities for developing novel treatment solutions for patients suffering from memory loss due to dementia-related conditions such as Alzheimer
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:39:47Scientists discover new treatment for dementia
Rice University scientists have found the balance necessary to aid healing with high-tech hydrogel.
Rice chemist Jeffrey Hartgerink, lead author Vivek Kumar and their colleagues have created a new version of the hydrogel that can be injected into an internal wound and help it heal while slowly degrading as it is replaced by natural tissue.
Hydrogels are used as a scaffold upon which cells can build tissue. The new hydrogel overcomes a host of issues that have kept them from reaching their potential to treat injuries and forming new vasculature to treat heart attack, stroke and ischemic tissue diseases.
The Rice lab
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:39:55Hydrogels deliver on blood-vessel growth
Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data. In a new study, investigators examined three parallel, prospective, ongoing, cumulative registry studies of over 1,000 men. Their analysis showed that long-term T therapy in hypogonadal men is safe and does not increase the risk of PCa.
Lead investigator Ahmad Haider, MD, PhD, urologist, Bremerhaven, Germany, states, ‘Although considerable evidence exists indicating no relationship between testosterone and increased risk of developing PCa, decades of physician training with the notion that testosterone is fuel for PCa made it difficult to dispel such fallacy and the myth continued to persist. Nevertheless, in the absence of long-term follow-up data demonstrating reduced risk of PCa in hypogonadal men who are receiving T therapy, considerable skepticism remains throughout the medical community and this is an expected natural and acceptable path of medical and scientific discourse. In view of the current evidence, clinicians are compelled to think this over and cannot justify withholding T therapy in hypogonadal men, also in men who have been successfully treated for PCa.’
EurekAlert
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:40:03Long-term testosterone therapy does not increase the risk of prostate cancer
Undescended testis is commonly found in new-born boys and usually normalizes spontaneously by the age of six months. In one in a hundred boys, however, at least one testis remains undescended
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:40:10Undescended testis: The recommended surgery is being performed too late
The Critical Care Recovery Center care model — the USA
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:39:50New care model enhances recovery of ICU survivors
A simple point-of-care testing device for anemia could provide more rapid diagnosis of the common blood disorder and allow inexpensive at-home self-monitoring of persons with chronic forms of the disease. The disposable self-testing device analyses a single droplet of blood using a chemical reagent that produces visible colour changes corresponding to different levels of anemia. The basic test produces results in about 60 seconds and requires no electrical power. A companion smartphone application can automatically correlate the visual results to specific blood hemoglobin levels. By allowing rapid diagnosis and more convenient monitoring of patients with chronic anemia, the device could help patients receive treatment before the disease becomes severe, potentially heading off emergency room visits and hospitalizations. Anemia, which affects two billion people worldwide, is now diagnosed and monitored using blood tests done with costly test equipment maintained in hospitals, clinics or commercial laboratories. Because of its simplicity and ability to deliver results without electricity, the device could also be used in resource-poor nations. Using a two-piece prototype device, the test works this way: a patient sticks a finger with a lance similar to those used by diabetics to produce a droplet of blood. The device
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:39:58One-minute point-of-care anemia test shows promise in new study
Survey of Swedish anesthesia personnel reveals the need to improve knowledge, particularly in elderly and fragile patients. Postsurgical cognitive side effects can have major implications for the level of care, length of hospital stay, and the patient
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:40:05Survey finds low awareness about risks of cognitive side effects following surgery
No methods currently exist for the early detection of Alzheimer
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:39:472020-08-26 14:39:53MRI probe technology shows brain toxins in living animals for first time
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.